Latest Governance News

ActivEX Limited reported robust exploration progress in Q4 2024, highlighted by significant high-grade gold intercepts at Mt Hogan and the securing of a rare earth elements tenement at Doonkuna. The company maintains a cautious cash position supported by a substantial loan facility.

Lumos Diagnostics reported a robust Q2 FY25 with a 71% revenue increase to US$2.9 million, driven by strong product and service sales, alongside a strategic US$3 million BARDA partnership to advance its FebriDx test.

Peel Mining's December 2024 quarterly report reveals exceptional high-grade copper, gold, silver, lead, and zinc intercepts at Wagga Tank, highlighting significant potential for resource expansion within open-pittable depths. Concurrently, fieldwork advances at the Curnamona Project and a solid cash position underpin the company's growth trajectory.

Bayan Mining and Minerals has secured exploration rights over a 13,406-hectare gold-rich area in southern Brazil, positioning itself near significant gold anomalies and withdrawing from its Canadian lithium option to focus on high-potential assets.

Green Technology Metals (ASX: GT1) secures a Letter of Interest for up to C$100 million financing from Export Development Canada, underpinning its Seymour Lithium Project and advancing drilling and development across its Ontario lithium hubs.

ABx Group reports significant progress in its rare earths and bauxite ventures, including enhanced geological models and pilot plant developments supported by key partnerships and government backing.

Native Mineral Resources has secured key Queensland gold assets and is advancing refurbishment of the Blackjack Processing Plant, targeting production restart by Q3 2025. The company’s recent capital raises underpin its ambitious development plans.

Nimy Resources advances its Mons Project with significant high-grade copper and gallium mineralisation confirmed at Masson and Block 3 East prospects, supported by a successful capital raise and a CSIRO research grant.

Optiscan Imaging Ltd reported a productive December quarter, marked by key product developments, strategic partnerships, and a stronger cash position, setting the stage for growth in medical and veterinary imaging markets.

Lefroy Exploration Limited reported a modest net cash decrease in the December quarter, ending with $3.24 million in cash reserves and nearly four quarters of funding available. The company continues to invest heavily in exploration activities despite operating cash outflows.

Dubber Corporation Limited reports steady revenue growth and cost reductions in Q2 FY25, alongside a refreshed board and strategic initiatives aimed at achieving operating cashflow breakeven by year-end.

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.